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Abstract
Fibroblasts derived from glucose-6-phosphate dehydrogenase (G6PD)-deficient patients display
retarded growth and accelerated cellular senescence that is attributable to increased accumulation
of oxidative DNA damage and increased sensitivity to oxidant-induced senescence, but not to
accelerated telomere attrition. Here, we show that ectopic expression of hTERT stimulates
telomerase activity and prevents accelerated senescence in G6PD-deficient cells. Stable clones
derived from hTERT-expressing normal and G6PD-deficient fibroblasts have normal karyotypes,
and display no sign of senescence beyond 145 and 105 passages, respectively. Activation of
telomerase, however, does not prevent telomere attrition in earlier-passage cells, but does stabilize
telomere lengths at later passages. In addition, we provide evidence that ectopic expression of
hTERT attenuates the increased sensitivity of G6PD-deficient fibroblasts to oxidant-induced
senescence. These results suggest that ectopic expression of hTERT, in addition to acting in
telomere length maintenance by activating telomerase, also functions in regulating senescence
induction.
Background
Normal human cells grown in vitro replicate for a limited
period of time before entering senescence [1], a term that
has been used primarily to describe a signal transduction
pathway that leads to the irreversible growth arrest of cells
in culture. Among the various stimuli that are known to
trigger senescence [2,3], telomere attrition and oxidative
damage (produced during normal cellular proliferation)
are the basis for the "telomere hypothesis" [4,5] and "free
radical theory" [6,7], respectively, postulated to account
for the aging process.
According to the "telomere hypothesis" of aging, dysfunc-
tional telomeres caused by telomere attrition are postu-
lated to initiate the senescent phenotypes. Telomere
attrition occurs because the ends of linear chromosomal
DNA cannot be completely replicated by normal DNA
polymerases, and, therefore, telomere DNA becomes
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shortened with each round of DNA replication [8,9].
When telomeres reach a critical length, they become dys-
functional and trigger so-called replicative senescence.
Activation of telomere length-maintenance mechanisms,
such as expression of telomerase, a specialized reverse
transcriptase that synthesizes telomeric DNA repeats at
chromosome ends, is thought to counteract replicative
senescence [5,10,11]. In support of this postulate, normal
human somatic cells express low or undetectable telomer-
ase activity and are mortal. In contrast, a majority of
immortal and cancer cells have an indefinite proliferative
capacity and maintain their telomere length by upregulat-
ing telomerase [12,13]. Ectopic expression of telomerase
has been shown to extend the lifespan of many normal
human cells cultured in vitro [14-16].
The free radical theory of aging postulates that the accu-
mulation of oxidative damage is the central mediator of
the aging process [6,7]. Reactive oxygen species produced
during normal cellular metabolism or from exogenous
sources, such as drugs and radiation, are known to react
with biomolecules, including proteins and DNA. It is this
accumulation of oxidative damage over time that is postu-
lated to trigger senescence [6]. In support of this hypothe-
sis, exposure to oxidative stress (e.g., tert-butyl
hydroperoxide, hydrogen peroxide, or a hyperbaric
atmosphere with high O2 partial pressure) triggers senes-
cence, and oxidative DNA damage is known to accrue dur-
ing senescence [17-23]. In addition, growth of cells under
hypoxic conditions (3% [v/v] O2 instead of the normal
atmospheric O2 level) is known to delay cellular senes-
cence of fibroblasts [24].
Despite supporting evidence for both of these theories,
based on multiple experimental approaches, little is
known about the relative roles of these two mechanisms
in the induction of senescence or the potential interac-
tions of the signaling pathways they trigger. Recently, we
have shown that fibroblasts derived from glucose-6-phos-
phate dehydrogenase (G6PD)-deficient patients dis-
played retarded growth and accelerated cellular
senescence [25]. Evidence indicates that the accelerated
cellular senescence observed in G6PD-deficient cells arises
because of increased accumulation of oxidative DNA
damage and an increased sensitivity to oxidant-induced
senescence, but not to accelerated telomere attrition [26].
These data indicate that G6PD status – and thus proper
redox balance – is a determinant of cellular senescence. It
is not yet known, however, whether increased oxidative
DNA damage is the only important determinant of senes-
cence induction in G6PD-deficient cells. To address this
point, we asked whether activation of telomerase activity
might be capable of overcoming the accelerated senes-
cence observed in such cells. Here, we present evidence
that ectopic expression of hTERT, the key regulator of tel-
omerase, activates telomerase activity and prevents pre-
mature senescence in G6PD-deficient cells.
Materials and methods
Chemicals, enzymes and oligonucleotides
Dulbecco's modified Eagle's medium (DMEM), trypsin,
penicillin, streptomycin and amphotericin were pur-
chased from Gibco (Karlsruhe, Germany). The anti-G6PD
antibody was from Genesis Biotech (Taiwan). The anti-
actin antibody was from Santa Cruz Biotechnologies
(Santa Cruz, CA, USA). The antibiotic, G418 sulfate, was
from Promega (Madison, WI, USA). The TeloTAGGG
assay kit, alkaline phosphatase and protein kinase K were
from Roche (Roche, Mannheim, Germany). Taq DNA
polymerase was from Qiagen. The sequence and source of
TS and CX oligonucleotides have been described [27].
Cell culture
Normal human fibroblasts (HFF3) and G6PD-deficient
fibroblasts (HFF1) were routinely cultured in DMEM sup-
plemented with 10% fetal bovine serum, 100 units/ml
penicillin, 100 units/ml streptomycin and 0.25 mg/ml
amphotericin at 37°C in a humidified atmosphere con-
taining 5% CO2. Human fibrosarcoma cells (HT1080),
used as a positive control in soft agar and telomerase
assays, were from American Type Culture Collection
(ATCC). BOSC23 and PT67 cells were used for prepara-
tion of retroviral particles as previously described [26].
Plasmids, retroviral packaging and infection
The plasmid, pBABE-Puro-hTERT [28], a retroviral con-
struct that expresses hTERT, was kindly provided by Dr. E.
Blackburn. Retroviral packaging and infection were
accomplished as previously described [26], with the
exception that the retrovirus producer cells and hTERT-
expressing clones were selected in a medium containing 2
g/ml puromycin.
Telomerase activity assay
A PCR-based telomeric amplification protocol (TRAP)
was used to assay telomerase activity. The preparation of
cell extracts, the PCR amplification conditions, and the
analysis of PCR products by electrophoresis on polyacry-
lamide gel were as described [29].
Soft agar assay
To assay for contact-independent growth in soft agar, cells
were trypsinized and resuspended at 3.3 × 103 cells/ml in
supplemented DMEM containing 0.35% melted agarose.
Aliquots (1.5 ml) of cell suspension were poured into 10-
cm Petri dishes pre-solidified with 1.5 ml 0.5% agarose in
supplemented DMEM. The immobilized cells were grown
for 14 days in a humidified chamber at 37°C with 5%
CO2. Colonies were then photographed and counted.Journal of Biomedical Science 2009, 16:18 http://www.jbiomedsci.com/content/16/1/18
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Karyotyping of hTERT-expressing cells
Cytogenetic examination was performed with hTERT-
expressing cells at passage 11–14. After incubating with
0.06 g/ml colcemid for 16 h to arrest cells in mitosis,
fibroblasts were collected by trypsinization and fixed with
Carnoy's fixative (a 3:1 mixture of methanol and glacial
acetic acid). Fixed fibroblasts were placed on a glass slide,
air-dried and stained with a 6% Giemsa solution for 3.5
min. The number of chromosomes in at least 40 cells was
analyzed from each fibroblast preparation.
Assay for telomere length
Cell pellets were lysed in 1 M Tris-EDTA buffer (pH 7.4)
containing 0.5% SDS, and treated with 200 g/ml protei-
nase K for 18 h at room temperature. Genomic DNA was
then isolated by phenol-chloroform extraction. Genomic
DNA was digested with HinfI and RsaI, and DNA frag-
ments were separated by electrophoresis in 0.8% agarose
gels. The DNA fragments containing telomeric repeats
were identified by Southern blotting using a TeloTAGGG
telomere-length assay kit (Roche, Mannheim, Germany).
Average telomere fragment length (TFR) was determined
from measurements of the intensity of chemiluminescent
signals at each molecular mass, obtained by scanning the
radiogram using a Molecular Dynamics Personal Densito-
meter (Sunnyvale, CA, USA). Signal densities were ana-
lyzed with ImageQuaNT software (Molecular Dynamics),
and mean TRF lengths were calculated according to man-
ufacturer's recommendation.
Assay for H2O2-induced premature senescence
Premature senescence was tested in fibroblasts treated
with different concentrations of H2O2 for 1.5 h using
senescence-associated (beta)-galactosidase (SA--gal) as a
biomarker of senescence. After H2O2  treatment, the
medium was replaced with fresh complete medium, and
cells were cultured for 72 h before staining for SA--Gal
activity as previously described [26]. Quantification of
premature senescence was determined by calculating the
rate of conversion of 4-methylumbellliferyl--D-galacto-
pyranoside (MUG) to the fluorescent product, 4-methyl-
umbelliferone (4-MU), at pH 6.0 as previously described
[30]. The relative increase in 4-MU fluorescence per mg
protein was determined by subtracting the untreated con-
trol values from the H2O2-treated values.
Results
Ectopic expression of hTERT immortalizes fibroblasts 
derived from normal and G6PD-deficient patients
To address the relative role of oxidative stress and tel-
omere attrition in cellular senescence, we asked whether
ectopic expression of hTERT might be capable of restoring
telomerase activity and extending the lifespan of G6PD-
deficient fibroblasts. Normal (HFF3) and G6PD-deficient
fibroblasts (HFF1) were infected with the retroviral con-
struct, pBABE-Puro-hTERT, which expresses hTERT under
the control of the LTR promoter, and G418-resistant
clones were screened for the expression of telomerase
activity. G418-resistant, telomerase-positive, clones from
infected normal fibroblasts (T5 and T9), or G6PD-defi-
cient fibroblasts (GT3 and GT8), were randomly selected
for further study. As shown in Figure 1, G418-resistant
cells from pBABE-Puro-hTERT-transfected normal and
G6PD-deficient fibroblasts expressed similarly high tel-
omerase activity that was comparable to that of a telomer-
ase-positive fibrosarcoma cancer cell line (HT1080),
whereas no telomerase activity was detected in G418-
resistant cells transfected with the pBABE-Puro vector.
To determine whether ectopic expression of telomerase
might be capable of extending the limited population
doublings previously observed for normal and G6PD-
deficient fibroblasts, we examined the proliferative capac-
ity of hTERT-expressing fibroblasts. As shown in Fig. 2A
and 2B, cells transfected with vector alone ceased to pro-
liferate after about 55 and 40 passages for V1 and GV1,
respectively. In contrast, hTERT-expressing fibroblasts
derived from normal or G6PD-deficient patients contin-
ued to proliferate over 105 passages and showed no evi-
dence of senescence, indicating that these cells were
immortal. Accompanying the acquisition of unlimited
growth potential in these fibroblasts was stable expression
of telomerase activity, which persisted over the entire time
of cell propagation (Fig. 2C).
hTERT-immortalized G6PD-deficient fibroblasts do not 
exhibit a transformed phenotype
To address the possibility that hTERT-immortalization of
G6PD-deficient fibroblasts could induce changes associ-
ated with a transformed phenotype, we examined karyo-
type and anchorage-independent growth. Representative
results of a karyotype analysis are shown for T5 and GT3
in Figure 3A. Both the hTERT-expressing normal and
G6PD-deficient fibroblasts had a normal complement of
diploid chromosomes (i.e., 46 + XY), and no abnormal
chromosomal structures (e.g., translocations) were
detected from a total of 20 cells analyzed in each prepara-
tion. To analyze anchorage-independent growth, we
examined the ability of hTERT-expressing normal and
G6PD-deficient fibroblasts to form colonies in soft agar
(Fig. 3B). Whereas the fibrosarcoma HT1080 cells dis-
played 60% colony-forming efficiency, colony formation
was not detected in hTERT-expressing normal or G6PD-
deficient fibroblasts from six independent experiments
with 5 × 103 cells plated in each experiment, indicating
that these immortal cells do not acquire an anchorage-
independent growth phenotype.Journal of Biomedical Science 2009, 16:18 http://www.jbiomedsci.com/content/16/1/18
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Telomere length stabilizes after reaching a critical length 
in hTERT-expressing G6PD-deficient fibroblasts
Expression of telomerase is thought to counteract tel-
omere attrition and thus provide escape from replicative
senescence. To determine whether the ectopic expression
of hTERT stabilizes telomere length in G6PD-deficient
fibroblasts, we analyzed TRF lengths. As shown in Figure
4A, telomere length continued to decrease in hTERT-
expressing normal fibroblasts, T5 and T9, in early-passage
cells, despite the fact that these cells express high levels of
telomerase activity. After passage 36, the TRF length in T5
cells appeared to stabilize at approximately 3.3 kb,
whereas TRF length in T9 cells increased in later passages,
increasing from ~3.3 kb to 6.2–8.5 kb. Both hTERT-
expressing G6PD-deficient fibroblasts, GT3 and GT8, dis-
played a pattern of telomere length reduction and stabili-
zation that was similar to that of normal T5 cells, with TRF
decreasing in earlier-passage cells but then stabilizing at
3–3.7 kb after passage 36 (Fig. 4B).
Resistance of hTERT-expressing G6PD-deficient 
fibroblasts to H2O2-induced premature senescence
To address the mechanism by which ectopic expression of
hTERT enables G6PD-deficient cells to overcome prema-
ture senescence, we measured the ability of hTERT-
expressing cells to cope with oxidative stress induced by
treatment with exogenous H2O2. As shown in Figure 5A,
under normal culture conditions there were very few cells
among G6PD-deficient HFF1 fibroblasts (passage 22) and
hTERT-expressing G6PD-deficient GT3 fibroblasts (pas-
sage 72) that were positive for SA--Gal staining (less than
5%). Treatment with H2O2 increased the number of SA--
Gal-positive cells in both the HFF1 and GT3 populations,
indicating that H2O2induces premature senescence in
both cells. Interestingly, we noted that there is a greater
increase of SA--Gal-positive cells in the H2O2-treated
HFF1 cells (55 ± 9%) than in the H2O2-treated GT3 cells
(21 ± 1.4%). To confirm the significance of this observa-
tion, we treated parental and hTERT-expressing fibroblasts
Telomerase activity of hTERT-transfected normal and G6PD-deficient fibroblasts Figure 1
Telomerase activity of hTERT-transfected normal and G6PD-deficient fibroblasts. Normal fibroblasts HFF3 and 
G6PD-deficient fibroblasts HFF1 were infected with retroviral vector pBABE-Puro (Panel A) or pBABE-Puro-hTERT (Panel B). 
G418-resistant clones were obtained from HFF3 infected with vector alone (V1, V2) or with pBABE-Puro-hTERT (T5, T9), and 
from HFF1 cells infected with vector alone (GV1, GV2) or with pBABE-Puro-hTERT (GT3, GT8). Telomerase activity in these 
G-418 resistant clones was assayed by TRAP as described in M & M. Lanes labeled with N, P, H are negative control with no 
cell extract, positive control with cell extract from a telomerase-positive HT-1080 cells, and heat-inactivated HT-1080 cell 
extract, respectively.Journal of Biomedical Science 2009, 16:18 http://www.jbiomedsci.com/content/16/1/18
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Proliferation capability of hTERT-transfected normal and G6PD-deficient fibroblasts Figure 2
Proliferation capability of hTERT-transfected normal and G6PD-deficient fibroblasts. Normal fibroblasts HFF3 
(Panel A) and G6PD-deficient fibroblasts HFF1 (Panel B) were infected with retroviral vector pBABE-Puro or pBABE-Puro-
hTERT, and G418-resistant clones were obtained as described in legend to Fig. 1. These G418-resistant cells were cultivated 
by successive passages with 1:8 spliting. The telomerase activity of hTERT-transfected T5 and GT3 cells at various passages 
(p13 to p72) was determined by TRAP and shown in Panel C. Lanes labeled with N, P, H in Panel C are negative control with 
no cell extract, positive control with cell extract from a telomerase-positive HT-1080 cells, and heat-inactivated HT-1080 cell 
extract, respectively.Journal of Biomedical Science 2009, 16:18 http://www.jbiomedsci.com/content/16/1/18
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The karyotypes and anchorage-independent growth potential of hTERT-expressing normal and G6PD-deficient fibroblasts Figure 3
The karyotypes and anchorage-independent growth potential of hTERT-expressing normal and G6PD-defi-
cient fibroblasts. The karyotypes of hTERT-expressing normal fibroblasts (T5) and G6PD-deficient fibroblasts (GT3) were 
determined as described in Materials and Methods; representative data are shown in panel A. Anchorage-independent growth 
was assayed by the ability to form colonies in soft agar. Representative results for hTERT-expressing G6PD-deficient fibrob-
lasts are shown in panel B (right panel); no colonies formed and only single cells were detected. In HT1080 fibrosarcoma cell 
positive controls, colonies were detected (left panel).Journal of Biomedical Science 2009, 16:18 http://www.jbiomedsci.com/content/16/1/18
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Telomere lengths of hTERT-expressing normal and G6PD-deficient fibroblasts Figure 4
Telomere lengths of hTERT-expressing normal and G6PD-deficient fibroblasts. Cells were cultivated successively 
by 1:8 spliting in each passage. The telomere lengths of hTERT-expressing normal fibroblasts (Panel A) and G6PD-deficient 
fibroblasts (Panel B) at different passages were determined as described in M & M. Lanes S and L are controls supplied with the 
assay kit for DNAs having short or long TRF lengths, respectively. Lane P is the DNA from the parental cells before transfec-
tion. The mean telomere restriction fragment (TRF) lengths in kilobases (kb) are indicated below each lane. Molecular weight 
(M.W.) markers ranging from 1.6 to 21.2 kb are marked at the left.Journal of Biomedical Science 2009, 16:18 http://www.jbiomedsci.com/content/16/1/18
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H2O2-induced senescence in G6PD-deficient fibroblasts Figure 5
H2O2-induced senescence in G6PD-deficient fibroblasts. A. Cells were treated with 350 M H2O2 for 1.5 h and then 
cultured for another 72 h before staining for senescence-associated -galactosidase (SA--Gal) activity. Representative results 
for HFF1 and GT3 cells with or without H2O2 treatment are shown in the right and left panels, respectively. Examples of cells 
that are positive for SA--Gal staining are indicated by arrow. In the quantification, any cell that has detectable green staining 
was scored as positive for SA--Gal. B. Cells were treated with different concentrations of H2O2 for 1.5 h and then cultured 
for another 72 h. Quantification of premature senescence was determined by the rate of conversion of 4-methylumbellliferyl-
-D-galactopyranoside (MUG) to fluorescent product 4-methylumbelliferone (4-MU) as described in M & M. Both the early 
passage (p13) and late passage (p72) cells of T5, T9, GT3 and GT8 were included in this study. Data are the means ± SD from 
4 independent experiments.Journal of Biomedical Science 2009, 16:18 http://www.jbiomedsci.com/content/16/1/18
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from both normal and G6PG-deficient patients with dif-
ferent concentrations of H2O2 and quantified the extent of
H2O2-induced premature senescence. As shown in Figure
5B, the levels of H2O2-induced premature senescence in
the early passage (p13) and late passage (p72) cells of T5,
T9, GT3 and GT8 were similar to HFF3, but were signifi-
cantly greater in HFF1 cells. These results indicate that
ectopic expression of hTERT in G6PD-deficient cells
renders the cells more resistant to H2O2-induced prema-
ture senescence.
Discussion
The accelerated cellular senescence characteristic of
G6PD-deficient fibroblasts would seem to represent a
clear case of a senescence mechanism based on accumu-
lated oxidative DNA damage rather than one involving
accelerated telomere attrition [26]. This mechanistic
transparency makes these cells an ideal system for
addressing the relative role of oxidative stress and tel-
omere attrition in cellular senescence. Somewhat surpris-
ingly, we found that ectopic expression of hTERT
prevented the accelerated senescence of G6PD-deficient
cells and led to their immortalization (Fig. 2). The growth
rate of hTERT-expressing G6PD-deficient fibroblasts,
however, remained slower than that of hTERT-expressing
normal fibroblasts (Fig. 2A and 2B), as noted previously
(25). This finding suggests that hTERT overexpression
may attenuate senescence induction by oxidative stress,
but does not suppress the growth defect caused by G6PD-
deficiency. To test this hypothesis, we measured the abil-
ity of hTERT-expressing G6PD-deficient cells to cope with
H2O2-induced oxidative stress. Similar to results reported
by others [31], we found no difference in stress-induced
premature senescence (SIPS) between normal and hTERT-
expressing normal fibroblasts (Fig. 5). However, hTERT-
expressing G6PD-deficient cells became more resistant to
H2O2-induced premature senescence (Fig. 5), indicating
that the increased sensitivity to oxidative stress in G6PD-
deficient cells is prevented by the expression of hTERT.
Ectopic expression of hTERT has also been shown previ-
ously to immortalize fibroblasts derived from individuals
with Ataxia telangiectasia (A-T), Nijimegen breakage syn-
drome (NBS), Hutchinson-Gilford progeria syndrome
(HGPS), and Werner Syndrome (WS) [32-36]. Although
the genetic defects in A-T, NBS, HGPS, WS, and G6PD-
deficiency patients are very different, fibroblasts derived
from these individuals have one common phenotype:
they all undergo accelerated senescence in vitro
[25,34,36,37]. The premature senescence of mitotic cells
derived from A-T, HGPS, and NBS patients has been cor-
related with an increased rate of telomere loss [31,34,38],
whereas the mechanism responsible for the premature
senescence of WS and G6PD-deficient fibroblasts appears
to be different and has been postulated to reflect the accu-
mulation of DNA damage [26,38]. The fact that ectopic
expression of hTERT immortalizes fibroblasts derived
from individuals with any of these different defects indi-
cates that telomerase may attenuate senescence induction
triggered by either telomere attrition or genome-wide
DNA damage. Ectopic expression of hTERT has also been
shown to increase radioresistance of adult human mesen-
chymal stem cells [39], to circumvent hyperglycemia-
induced premature senescence [40], and to prevent apop-
tosis induced by tumor necrosis factor [41]. These obser-
vations suggest that expression of hTERT not only
activates telomere maintenance but may also affect signal-
ing that protects cells from oxidative stress and other stim-
uli. Indeed, increasing evidence is emerging to implicate
that hTERT has functions beyond telomere maintenance
[42].
hTERT-immortalization of cells is generally attributed to
the activation of telomerase activity and the subsequent
counteraction of telomere attrition. Surprisingly, we
observed that telomere lengths continued to decrease in
earlier-passage cells from both hTERT-expressing normal
and G6PD-deficient fibroblasts, despite the fact that these
cells expressed high levels of telomerase activity (Fig. 1).
In fact, we observed that TRF lengths from one hTERT-
expressing normal cell line (T5) and two hTERT-express-
ing G6PD-deficient cell lines (GT3 and GT8) were short-
ened to ~3–3.7 kb before stabilization (Fig. 4). The
parental fibroblasts used for the derivation of these
hTERT-expressing cells undergo senescence when TRF
lengths decrease to approximately 5–6 kb [25], suggesting
that dysfunctional telomeres may already have formed
when the TRF length was reduced to 5–6 kb in normal
fibroblasts. However, senescence was not induced in these
hTERT-expressing cells even when the TRF lengths were
reduced to less than 5 kb, suggesting that hTERT, in addi-
tion to serving as a subunit for telomerase, acts by some
other mechanism to prevent senescence induction. Short-
ening of telomere lengths in the presence of telomerase
activation has also been observed by others [28,43], and a
protective role for hTERT in telomere capping has been
suggested [28,44]. In addition, hTERT has been found to
associate with human telomeres, and ectopic expression
of hTERT causes transcriptional alterations in a subset of
genes; this may lead to increased genomic stability and
enhanced DNA repair activity [45]. At this time, the
molecular details of hTERT involvement in senescence
induction remain obscure.
It is currently not known why activation of telomerase
does not result in an immediate stabilization of telomere
lengths. Presumably, telomere length is influenced not
only by telomerase levels but also depends on a control
pathway that acts in cis at each individual telomere [46].
Several telomere-binding proteins, such as TRF1, TRF2,Journal of Biomedical Science 2009, 16:18 http://www.jbiomedsci.com/content/16/1/18
Page 10 of 11
(page number not for citation purposes)
and Pot1, are known to participate in telomere-length reg-
ulation and chromosome-end protection [46]. It is likely
that some of these factors prevent telomerase from func-
tioning at the telomere until telomeres are shortened to a
critical length. Our finding that the lengths of telomeres in
hTERT-expressing cells were reduced to approximately 3–
3.7 kb before stabilization (Fig. 4) provides support for
this notion.
In conclusion, we have shown that ectopic expression of
hTERT immortalizes fibroblasts derived from normal and
G6PD-deficient patients. The accelerated cellular senes-
cence observed in G6PD-deficient cells has been shown to
be attributable to increased accumulation of oxidative
DNA damage [26]. As this oxidant-induced senescence
was overridden by the ectopic expression of hTERT, we
suggest that hTERT, in addition to providing a subunit for
telomerase, may also function in regulating senescence
induction.
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